Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis

(2010) Yan Wang et al.   JOURNAL OF HEPATOLOGY

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice

(2009) Kojiro Taura et al.   HEPATOLOGY

Smad6 Inhibits the Transcriptional Activity of Tbx6 by Mediating Its Degradation

(2009) Yue-Lei Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of a novel mouse P4-ATPase family member highly expressed during spermatogenesis

(2009) P. Xu et al.   JOURNAL OF CELL SCIENCE

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats

(2009) Thomas Reiberger et al.   JOURNAL OF HEPATOLOGY

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor

(2009) H. Huynh et al.   MOLECULAR CANCER THERAPEUTICS

Roles of TGFβ in metastasis

(2008) David Padua et al.   CELL RESEARCH

Hepatocyte-Specific Smad7 Expression Attenuates TGF-β–Mediated Fibrogenesis and Protects Against Liver Damage

(2008) Steven Dooley et al.   GASTROENTEROLOGY

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

(2008) Marc Mejias et al.   HEPATOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transcriptional regulation of cell polarity in EMT and cancer

(2008) G Moreno-Bueno et al.   ONCOGENE

Hepatic fibrogenesis: From within and outwith

(2008) Neil C. Henderson et al.   TOXICOLOGY